The Recall Desk
SevereFDA (Devices)·Z-2975-2026·Announced 2026-08-26

Siemens Quinidine Assay Recalled for Precision Errors

Siemens is recalling 20 units of the Syva EMIT 2000 Quinidine Assay due to precision issues that may cause inaccurate test results.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The source explicitly states the defect creates a risk of 'potential life-threatening cardiac arrhythmias,' which aligns with the rubric criterion for 'significant injury' reports or risks.

Plain-English summary

Siemens Healthcare Diagnostics, Inc. is recalling 20 units of the Syva EMIT 2000 Quinidine Assay (REF: 4Q019UL, Lot U1/UDI: 00842768001048). The affected units were distributed in California and Italy.

The recall is due to unacceptable precision performance in certain lots of the assay. This defect may lead to erroneously elevated quinidine measurements, which creates a risk of sub-optimal patient treatment. Such treatment errors could result in potential life-threatening cardiac arrhythmias or inadequate antimalarial therapy.

Healthcare providers and facilities that have received this specific lot should stop using the product and contact Siemens Healthcare Diagnostics for instructions on return or disposal.

The recalled product

Product
Syva EMIT 2000 Quinidine Assay REF: 4Q019UL Contents: 1x28 mL, 1x14mL
Affected units
20

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot U1/UDI: 00842768001048

Distribution

Distributed nationwide across the United States.

The notice also names 1 state specifically: